US2312381A - Medicinal tablet - Google Patents

Medicinal tablet Download PDF

Info

Publication number
US2312381A
US2312381A US362693A US36269340A US2312381A US 2312381 A US2312381 A US 2312381A US 362693 A US362693 A US 362693A US 36269340 A US36269340 A US 36269340A US 2312381 A US2312381 A US 2312381A
Authority
US
United States
Prior art keywords
tablet
aspirin
effervescent
tablets
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US362693A
Inventor
Frank J Bickenheuser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US362693A priority Critical patent/US2312381A/en
Application granted granted Critical
Publication of US2312381A publication Critical patent/US2312381A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Definitions

  • This invention relates to tablets designed primarily for use in administering such medicines as are to be dissolved by chemical action of a substance that it itself soluble in the liquid in which the said medicine is to be dissolved.
  • An object of the invention is to provide a tablet which can be made up of chemicals and medicines which, ordinarily if in contact with each other, would react chemically one upon the other so as to be rendered ineificient or of reduced efliciency, means being employed whereby these medicines or chemicals are prevented from acting upon each other until just before they are to be consumed.
  • liquid e. g.- water
  • a further object is to provide a product in which two preparations such as aspirin and an effervescent mixture or material, are combined in a single tablet.
  • two preparations such as aspirin and an effervescent mixture or material
  • the aspirin is readily soluble in such solution and hence is more efiectivethan when taken alone.
  • the useful results would not be obtained merebybyby combining these two ingredients into one tablet, for the reason that in the presence of stronger solutions of alkali, the aspirin (acetyl-salicylic acid) is to a considerable extent, hydrolyzed, leaving sodium salicylate and sodium acetate.
  • the present invention has for an object the formation of a tablet made up essentially of aspirin and an effervescent material preferably giving by reaction a soluble sodium salt.
  • the components of the effervescent mixture will'not react one upon the other, in the dry state, but these rapidly react with each other when the tablet is dropped into water, with the evolution of gas bubbles.
  • FIG. 1 is an enlarged plan view of a tablet constructed in accordance with one embodiment of the present invention.
  • Figure 2 is a central transverse section therethrough.
  • Figure 3 is a detail view illustrating portions of two tablets positioned edge to face and showing how the annular portion 5 is kept out of contact with the inner portion I if the tablets are packed in bulk.
  • Figure 4 shows a section of a modification in which the top and bottom of the annular casing of effervescent salt mixture, and the top and bottom of the aspirin tablet are both flat.
  • Figure 5 is a section of another form in which the top and bottom of the tablet of aspirin are outwardly curved, as in many of the aspirin -tablets now on the market.
  • l designates the inner or central section of the tablet preferably formed with a centralopenportion of the effervescent mixture forming another portion of the tablet.
  • of the aspirin and at the ing 2 and the opposed faces of this central portion may be concave as indicated at 3.
  • a protecting material or shielding layer 4 preferably soluble in water is applied to the periphery of the central portion l-and constitutes the base on which is applied the outer or peripheral portion 5 of the tablet, this latterportion being formed preferably of an effervescent mixture tightly compressed and preferably tapered outwardly toward its periphery.
  • the alkali in the effervescent material would, (in the absence of the ring of inert soluble material 4) normally attack the aspirin chemi cally and reduce its efficiency, such objectionable result is-prevented in the present instance because of the interposed annular shield 4 which can be of a material. readily soluble in water, as for example, glucose.
  • the outer annular portion 5 is preferably of much greater thickness than the inner portion I so that it is thus possible to stack the tablets one upon the other and package them,
  • the tablet When it is desired to use the tablet, the same is dropped into a convenient quantity of water, say in a drinking glass, and the materials forming the annular portion 5 immediately begin to react and to efl'ervesce. If the tablet is in a substantially horizontal position, a substantial percentage of the generated gas will escape upwardly through the opening 2. If the tablet is in an inclined or vertical position, portions of the gas generated will flow along one or both of the surfaces of the inner portion I. Under any conditions the tablet is completely dissolved or-put completely into solution, due to the agitation resulting from the release of the gases and due to the mildly alkaline nature of the solution of the material 5. Thus when the medicine is administerediit will have maximum therapeutic value because of its use with the effervescent material.
  • the layer 4 also will dissolve slowly, during the .act of solution of the aspirin.
  • This layer need not be of glucose, but can be of various compositions, water-soluble gums, sugars, inert salts with no bad taste, etc. being suitable. This could also be of a material that is inert to the materials I and 5, but which has a medicinal value.
  • the effervescent mixture may be made up from '75 parts powdered citric acid, parts of sodium bicarbonate and 55 parts of powdered tartaric acid. (If desired 54 parts of this sodium bicarbonate could be substituted by 24 parts of lithium carbonate, to give soluble lithia in the tablet).
  • effervescent mixtures are 2 parts each of tartaric acid and sodium bicarbonate with .1 part of an' inert material, or 4 parts sodium bicarbonate, 1 part tartaric acid and 2 parts citric acid, with 1-3 parts lactose.
  • Such effervescent mixtures can preferably be very slightly moistened with strong alcohol, before being compressed into the annular shape shown.
  • acid materials-in such effervescent compositions I is rather wide, numerous organic or inorganic acid salts re. g. mucic acid, acid phosphates, sodium bisulphate, potassium bitartrate are a few examples), and these acids or acid salts may react with the carbonates or bicarbonates to give medicinally useful products, or not, as, desired.
  • the potassium bitartrate acting on the soda gives Rochelle salt, useful as a laxative.
  • the encircling ring of effervescent salt is not much thicker than the aspirin tablet.
  • Suchtablets could be dispensed in tubular bottles, only slightly larger in diameter than the tablet. paper rolls, like a stack of coins in a tubular paper wrapper. The tablets shown in the drawing can. be dispensed in a similar manner.
  • the invention is useful as furnishing aspirin or various other medicines which are-insoluble or diflicultly soluble in watertor other selectedliquid vehicle.
  • a medicinal tablet for being dissolved in. a selected potable liquid including a medicinal central thin'portion composed of amedicament not readily soluble in said potable liquid, an effervescent annular portion, and a protective layer between said portions, which layer is soluble in said potable liquid,the thicknessrof the central portion being less than the thickness of a neighboring portion of the said annular portion, thereby to provide central recesses in the opposed faces of the tablet, and the curvature of the periphery. of the annular portion and the Or they could be dispensed in oiled'

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

March 2, 1943.
F. J. BICKENHEUSER MEDICINAL TABLET Filed Oct. 24, 1940 v I ff J15); cWenhe/user Patented Mar. 2, 1943 UNITED STATES PATENT OFFICE MEDICINAL H TABLET Frank J.-Bickenheuser, Tulsa, Okla. Application October 24, 1940, Serial No. 362,693
1 Claim.
This invention relates to tablets designed primarily for use in administering such medicines as are to be dissolved by chemical action of a substance that it itself soluble in the liquid in which the said medicine is to be dissolved. An object of the invention is to provide a tablet which can be made up of chemicals and medicines which, ordinarily if in contact with each other, would react chemically one upon the other so as to be rendered ineificient or of reduced efliciency, means being employed whereby these medicines or chemicals are prevented from acting upon each other until just before they are to be consumed.
It is a further object of the invention .to provide a tablet which is not held within a protective casing or film but, on the contrary, is (at the time of use) exposed to direct contact with liquid (e. g.- water) into which it may be placed in its original undissolved state, whereby prompt solution is effected and the medicine thereby rendered readily effective when taken,-without an intermediate period during which a protective coating must be dissolved, as is the case when taking a medicine inclosed in a capsule.
A further object is to provide a product in which two preparations such as aspirin and an effervescent mixture or material, are combined in a single tablet. It is well known to the medical profession and the laity in general that when aspirin is administered with a dilute solution of sodium bicarbonate, the aspirin is readily soluble in such solution and hence is more efiectivethan when taken alone. For ordinary purposes, the useful results would not be obtained merebyby combining these two ingredients into one tablet, for the reason that in the presence of stronger solutions of alkali, the aspirin (acetyl-salicylic acid) is to a considerable extent, hydrolyzed, leaving sodium salicylate and sodium acetate. The present invention has for an object the formation of a tablet made up essentially of aspirin and an effervescent material preferably giving by reaction a soluble sodium salt. The components of the effervescent mixture will'not react one upon the other, in the dry state, but these rapidly react with each other when the tablet is dropped into water, with the evolution of gas bubbles. I
It is a further object to provide a tablet so shaped that, when the'tablets are placed One upon the other, the aspirin portion of each tablet is at all times protected from direct contact with any same time to dissolve a protective medium which constitutes a part of the tablet and which is interposed between the aspirin and the efiervescent composition contained in the tablet.
With the foregoing objects in view and others which will appear as the description proceeds, the invention consist of certain novel details of construction and combinations of parts hereinafter more fully described and pointed out in the claim, it being understood that changes may be made in the construction and arrangement of parts without departing from the spirit of the invention as claimed.
In the accompanying drawing several of the preferred forms of the invention have been shown.
In said drawing Figure 1 is an enlarged plan view of a tablet constructed in accordance with one embodiment of the present invention.
Figure 2 is a central transverse section therethrough. v
Figure 3 is a detail view illustrating portions of two tablets positioned edge to face and showing how the annular portion 5 is kept out of contact with the inner portion I if the tablets are packed in bulk.
Figure 4 shows a section of a modification in which the top and bottom of the annular casing of effervescent salt mixture, and the top and bottom of the aspirin tablet are both flat.
Figure 5 is a section of another form in which the top and bottom of the tablet of aspirin are outwardly curved, as in many of the aspirin -tablets now on the market.
Referring to the figures by characters of reference, l designates the inner or central section of the tablet preferably formed with a centralopenportion of the effervescent mixture forming another portion of the tablet.
It is another object to so shape the tablet as to insure flow of a portion of the liberated gas against the inner portion of the tablet (the active medicinal material) regardless of the position of the tablet when submerged, thereby insuring sufficient agitation of the tablet to effect a perfect suspension and solution. of the aspirin and at the ing 2 and the opposed faces of this central portion may be concave as indicated at 3. A protecting material or shielding layer 4 preferably soluble in water is applied to the periphery of the central portion l-and constitutes the base on which is applied the outer or peripheral portion 5 of the tablet, this latterportion being formed preferably of an effervescent mixture tightly compressed and preferably tapered outwardly toward its periphery.
Although the alkali in the effervescent material would, (in the absence of the ring of inert soluble material 4) normally attack the aspirin chemi cally and reduce its efficiency, such objectionable result is-prevented in the present instance because of the interposed annular shield 4 which can be of a material. readily soluble in water, as for example, glucose. The outer annular portion 5 is preferably of much greater thickness than the inner portion I so that it is thus possible to stack the tablets one upon the other and package them,
or simply pour a selected number of the tablets 'into a carton, bottle or other bulk package, with no danger of the alkali component of the compressed effervescent material contacting with any portion of the aspirin. Thus deterioration of the tablet while in storage is prevented.
In Figures 4 and 5 modifications are shown, the dotted circles in these figures being put on to show the outline of another tablet, when packed in bulk.
When it is desired to use the tablet, the same is dropped into a convenient quantity of water, say in a drinking glass, and the materials forming the annular portion 5 immediately begin to react and to efl'ervesce. If the tablet is in a substantially horizontal position, a substantial percentage of the generated gas will escape upwardly through the opening 2. If the tablet is in an inclined or vertical position, portions of the gas generated will flow along one or both of the surfaces of the inner portion I. Under any conditions the tablet is completely dissolved or-put completely into solution, due to the agitation resulting from the release of the gases and due to the mildly alkaline nature of the solution of the material 5. Thus when the medicine is administerediit will have maximum therapeutic value because of its use with the effervescent material.
It is designed to have the two portions l and 5 of each tablet so balanced or-proportioned that all parts go into complete suspension or solution during the same time interval. Hence the more rapidly dissolving effervescent material 5 is of much greater bulk than the aspirin part I.
Importanceis attached to the fact that the tablet is not inclosed on encased as would be true should a capsule be employed for holding it. Instead the therapeutic elements are con stantly exposed so as to be quickly and simultaneously dissolved in water or other selected liquid.
The layer 4 also will dissolve slowly, during the .act of solution of the aspirin. This layer need not be of glucose, but can be of various compositions, water-soluble gums, sugars, inert salts with no bad taste, etc. being suitable. This could also be of a material that is inert to the materials I and 5, but which has a medicinal value.
I have showed the central hole in the tablet I, in the drawing. The hole can be omitted if desired, in which event the gas liberated below the tablet will turn the tablet over frequently, keeping the mixture well agitated until dissolved.
While a combination of aspirin and effervescent material has been described, it is to be understood that other combinations of medicines might be used to equal advantage. In every case the finished tablet is in one piece so that there is no danger at any time of separation of the ingredients while being stored or handled prior to use. By referring to Figure 3 it will be noted that even though the tablets should be packed in bulk with the edges of some tablets extending into the recesses in other tablets, the edge of the annular portions 5 will-be maintained out of contact with the inner portions I. Thus there is no contact of the (acid) aspirin, with the (alkaline) effervescentv material, which would lead to some reaction (though slow) between these, even though dry (as during long storage of the tablets in bulk, see Fig. 3), which would cause deterioration.
v As an example to which the invention is not The effervescent mixture may be made up from '75 parts powdered citric acid, parts of sodium bicarbonate and 55 parts of powdered tartaric acid. (If desired 54 parts of this sodium bicarbonate could be substituted by 24 parts of lithium carbonate, to give soluble lithia in the tablet). I
Other suitable effervescent mixtures are 2 parts each of tartaric acid and sodium bicarbonate with .1 part of an' inert material, or 4 parts sodium bicarbonate, 1 part tartaric acid and 2 parts citric acid, with 1-3 parts lactose. Such effervescent mixtures can preferably be very slightly moistened with strong alcohol, before being compressed into the annular shape shown.
acid materials-in such effervescent compositions I is rather wide, numerous organic or inorganic acid salts re. g. mucic acid, acid phosphates, sodium bisulphate, potassium bitartrate are a few examples), and these acids or acid salts may react with the carbonates or bicarbonates to give medicinally useful products, or not, as, desired. Thus the potassium bitartrate acting on the soda gives Rochelle salt, useful as a laxative.
In another modification, whichis cheaper to construct, the encircling ring of effervescent salt is not much thicker than the aspirin tablet. Suchtablets could be dispensed in tubular bottles, only slightly larger in diameter than the tablet. paper rolls, like a stack of coins in a tubular paper wrapper. The tablets shown in the drawing can. be dispensed in a similar manner.
The invention is useful as furnishing aspirin or various other medicines which are-insoluble or diflicultly soluble in watertor other selectedliquid vehicle. V
This application is in part a continuation of my copending application, Serial No. 269,202, filed April 21, 1939, which in turn is in part a continuation of an earlier application, Serial No. 182,905, filed December 31, 1937.
What is claimed is:
A medicinal tablet for being dissolved in. a selected potable liquid, including a medicinal central thin'portion composed of amedicament not readily soluble in said potable liquid, an effervescent annular portion, and a protective layer between said portions, which layer is soluble in said potable liquid,the thicknessrof the central portion being less than the thickness of a neighboring portion of the said annular portion, thereby to provide central recesses in the opposed faces of the tablet, and the curvature of the periphery. of the annular portion and the Or they could be dispensed in oiled'
US362693A 1940-10-24 1940-10-24 Medicinal tablet Expired - Lifetime US2312381A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US362693A US2312381A (en) 1940-10-24 1940-10-24 Medicinal tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US362693A US2312381A (en) 1940-10-24 1940-10-24 Medicinal tablet

Publications (1)

Publication Number Publication Date
US2312381A true US2312381A (en) 1943-03-02

Family

ID=23427139

Family Applications (1)

Application Number Title Priority Date Filing Date
US362693A Expired - Lifetime US2312381A (en) 1940-10-24 1940-10-24 Medicinal tablet

Country Status (1)

Country Link
US (1) US2312381A (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984543A (en) * 1957-03-19 1961-05-16 Pierre F Smith Stabilization of effervescent carbonate powders
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3082091A (en) * 1956-07-03 1963-03-19 Pierre F Smith Effervescing composition in particle form
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
US3146169A (en) * 1960-01-21 1964-08-25 Burroughs Wellcome Co Pharmaceutical formulations and their manufacture
US3856932A (en) * 1969-12-16 1974-12-24 M May Tablet of a chlorine releasing solid compound
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
US5553741A (en) * 1993-08-06 1996-09-10 River Medical, Inc. Liquid delivery device
US5571261A (en) * 1993-08-06 1996-11-05 River Medical, Inc Liquid delivery device
US5588556A (en) * 1993-08-06 1996-12-31 River Medical, Inc. Method for generating gas to deliver liquid from a container
US5700245A (en) * 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5976436A (en) * 1992-06-30 1999-11-02 Fisons Plc Process for production of medicament formulations
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US20060193909A1 (en) * 2005-02-07 2006-08-31 Stawski Barbara Z Breath freshening pressed tablets and methods of making and using same
US20070054014A1 (en) * 2005-02-07 2007-03-08 Stawski Barbara Z Breath freshening confectionery products and methods of making and using same
US20070166430A1 (en) * 2004-04-20 2007-07-19 Stawski Barbara Z Breath freshening confectionery products and methods of making and using same
USD666377S1 (en) 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD666376S1 (en) 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
WO2014043553A1 (en) * 2012-09-15 2014-03-20 Slaboden Jeffery K Dissolvable tablet
US20150182426A1 (en) * 2011-05-04 2015-07-02 Pollogen Ltd Apparatus and method for using effervescent tablets for cosmetic care
FR3016292A1 (en) * 2014-06-06 2015-07-17 Michel Lenois EFFERVESCENT TABLET COMPRISING CIRCULAR GROOVES ON BOTH SIDES
USD771236S1 (en) * 2015-12-15 2016-11-08 Johnson & Johnson Consumer Inc. Tablet
US9861902B1 (en) * 2016-07-07 2018-01-09 Rolando Perez Edible spinning device and method of operation
USD814126S1 (en) * 2015-08-26 2018-03-27 7905122 Canada Inc. Particle for animal litter

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3082091A (en) * 1956-07-03 1963-03-19 Pierre F Smith Effervescing composition in particle form
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
US2984543A (en) * 1957-03-19 1961-05-16 Pierre F Smith Stabilization of effervescent carbonate powders
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3146169A (en) * 1960-01-21 1964-08-25 Burroughs Wellcome Co Pharmaceutical formulations and their manufacture
US3856932A (en) * 1969-12-16 1974-12-24 M May Tablet of a chlorine releasing solid compound
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
US5976436A (en) * 1992-06-30 1999-11-02 Fisons Plc Process for production of medicament formulations
US5553741A (en) * 1993-08-06 1996-09-10 River Medical, Inc. Liquid delivery device
US5571261A (en) * 1993-08-06 1996-11-05 River Medical, Inc Liquid delivery device
US5588556A (en) * 1993-08-06 1996-12-31 River Medical, Inc. Method for generating gas to deliver liquid from a container
US5700245A (en) * 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US8557323B2 (en) 2004-04-20 2013-10-15 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
US10085771B2 (en) 2004-04-20 2018-10-02 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
US20070166430A1 (en) * 2004-04-20 2007-07-19 Stawski Barbara Z Breath freshening confectionery products and methods of making and using same
US20060193909A1 (en) * 2005-02-07 2006-08-31 Stawski Barbara Z Breath freshening pressed tablets and methods of making and using same
US8431150B2 (en) 2005-02-07 2013-04-30 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
US20070054014A1 (en) * 2005-02-07 2007-03-08 Stawski Barbara Z Breath freshening confectionery products and methods of making and using same
USD666376S1 (en) 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
USD666377S1 (en) 2010-12-01 2012-09-04 Kraft Foods Global Brands Llc Lozenge
US20150182426A1 (en) * 2011-05-04 2015-07-02 Pollogen Ltd Apparatus and method for using effervescent tablets for cosmetic care
US10251460B2 (en) * 2011-05-04 2019-04-09 Pollogen Ltd. Apparatus and method for using effervescent tablets for cosmetic care
US9949548B2 (en) * 2011-05-04 2018-04-24 Pollogen Ltd. Apparatus and method for using effervescent tablets for cosmetic care
WO2014043553A1 (en) * 2012-09-15 2014-03-20 Slaboden Jeffery K Dissolvable tablet
FR3016292A1 (en) * 2014-06-06 2015-07-17 Michel Lenois EFFERVESCENT TABLET COMPRISING CIRCULAR GROOVES ON BOTH SIDES
USD814126S1 (en) * 2015-08-26 2018-03-27 7905122 Canada Inc. Particle for animal litter
USD771236S1 (en) * 2015-12-15 2016-11-08 Johnson & Johnson Consumer Inc. Tablet
US20180008898A1 (en) * 2016-07-07 2018-01-11 Rolando Perez Edible spinning device and method of operation
US9861902B1 (en) * 2016-07-07 2018-01-09 Rolando Perez Edible spinning device and method of operation

Similar Documents

Publication Publication Date Title
US2312381A (en) Medicinal tablet
US3536074A (en) Oral administration of a pill,tablet or capsule
Juhlin et al. Urticaria and asthma induced by food-and-drug additives in patients with aspirin hypersensitivity
US4764375A (en) Sachet drug delivery system
US5912011A (en) Solvent system to be enclosed in capsules
US4427116A (en) Denitrifice encapsulation
GB1093286A (en) Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
KR870002832A (en) Pharmaceutical composition
SE8104881L (en) Capsule CONTAINING ACETYLSALICYLIC ACID AND AN ALKALIC MATERIAL
ES8503508A1 (en) Pharmaceutical compositions.
ES2134953T3 (en) GELATIN CAPSULES CONTAINING A HIGHLY CONCENTRATED ACETAMINOPHEN SOLUTION.
NO854391L (en) PHARMASOEYTIC MATRIX FOR THE IBUPROFEN.
KR830005854A (en) Method for preparing alkaline analgesic capsule
DE69429632D1 (en) DOSED FORM WITH CONTROLLED RELEASE FOR POTASSIUM
WO2006020522A2 (en) Multiplex drug delivery device
US3525426A (en) Drain cleaning cartridge
US1815902A (en) Device for administering medicaments
US2798837A (en) Achlorhydria composition
JP3187580B2 (en) Multilayer solid dialysis agent
US5665388A (en) Method for preparation of an alkaline and aspirin combination compound
GB800973A (en) Improvements in or relating to pills or tablets
US2071511A (en) Enteric coating
GB1221038A (en) Improvements in effervescent tablet compositions
US3316150A (en) Stable suspensions of acetyl salicylic acid
AU687420B2 (en) Soft-shelled gelatin encapsulated particles